Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin.

Faculty of Health and Medicine

Research output: Contribution to conference - Without ISBN/ISSN › Poster › peer-review

Published

Standard

Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin. / Spencer, Sally; Jones, Paul W.
2001. Poster session presented at European Respiratory Society Annual Conference, Berlin, Germany.

Research output: Contribution to conference - Without ISBN/ISSN › Poster › peer-review

Bibtex

@conference{b40e81c8e9194421a7237f4ddc0ce3b1,

title = "Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin.",

author = "Sally Spencer and Jones, {Paul W}",

year = "2001",

language = "English",

note = "European Respiratory Society Annual Conference ; Conference date: 22-09-2001 Through 26-09-2001",

}

RIS

TY - CONF

T1 - Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin.

AU - Spencer, Sally

AU - Jones, Paul W

PY - 2001

Y1 - 2001

M3 - Poster

T2 - European Respiratory Society Annual Conference

Y2 - 22 September 2001 through 26 September 2001

ER -

Research